MOBILE VIEW  | 

ASIAN SNAKES-VIPERIDAE

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Zoogeographically snakes of the Asia are difficult to delimit. Poisonous snakes of this region have been divided into two main categories, which are the Elapidae and the Viperidae (vipers, pit vipers, Viperinae (old world vipers) and Crotalinae (Asian pit vipers)). This management is limited to the Viperidae that inhabit, and are of medical importance to this region.
    B) Countries that are included in this management are as follows: Indian subcontinent, Pakistan, Sri Lanka, Myanmar (Burma), Thailand, China, Taiwan, Laos and Cambodia, Peninsular Malaysia, Philippines, Japan, South Korea, Vietnam, Indonesia, Iran, and Nepal (Meier & White, 1995).
    C) Please refer to the ASIAN SNAKES-ELAPIDAE management for further information on the Family Elapidae.
    D) Please refer to the SEA SNAKES management for further information on sea snakes.

Specific Substances

    A) CROTALINAE (ASIAN PIT VIPERS)
    1) Agkistrodon acutus (Asian Snakes list)
    2) Agkistrodon (Gloydius) blomhoffii blomhoffii (Japanese mamushi) (Asian Snakes list)
    3) Agkistrodon blomhoffii brevicaudus (Chinese mamushi) (Asian Snakes list)
    4) Agkistrodon halys (Siberian pit viper) (Asian Snakes list)
    5) Agkistrodon himalayanus (Hamalayan pit viper) (Asian Snakes list)
    6) Agkistrodon intermedius (Central Asian pit viper) (Asian Snakes list)
    7) Agkistrodon saxatilis (Rock mamushi) (Asian Snakes list)
    8) Agkistrodon shedaoenisis (Snake island mamushi) (Asian Snakes list)
    9) Agkistrodon ussuriensis (Ussuri mamushi) (Asian Snakes list)
    10) Agkistrodon monticola (Likiang pit viper) (Asian Snakes list)
    11) Agkistrodon strauchi (Tibetan pit viper) (Asian Snakes list)
    12) Calloselasma rhodostoma (Malayan pit viper) (Asian Snakes list)
    13) Deinagkistrodon acutus (Sharp-nosed pit viper or Hundred-pacer) (Asian Snakes list)
    14) Hypnale hypnale (Merrem's hump-nosed viper) (Asian Snakes list)
    15) Hypnale nepa (Sri Lankan hump-nosed) (Asian Snakes list)
    16) Hypnale walli (Wall's hump-nosed viper) (Asian Snakes list)
    17) Ovophis chaseni (Chasen's pit viper) (Asian Snakes list)
    18) Ovophis convictus (Penang pit viper) (Asian Snakes list)
    19) Ovophis monticola (Mountain pit viper) (Asian Snakes list)
    20) Ovophis okinavensis (Hime-habu or Kufah) (Asian Snakes list)
    21) Trimeresurus albolarbis (White-lipped green pit viper) (Asian Snakes list)
    22) Trimeresurus borneensis (Bornean pit viper) (Asian Snakes list)
    23) Trimeresurus brongersmai (Brongersma's pit viper) (Asian Snakes list)
    24) Trimeresurus cantori (Cantor's pit viper) (Asian Snakes list)
    25) Trimeresurus cornutus (Horned pit viper) (Asian Snakes list)
    26) Trimeresurus elegans (Sakishima-habu) (Asian Snakes list)
    27) Trimeresurus erythrurus (Red-tailed green pit viper) (Asian Snakes list)
    28) Trimeresurus fasciatus (Banded pit viper) (Asian Snakes list)
    29) Trimeresurus flavomaculatus (Yellow-spotted pit viper) (Asian Snakes list)
    30) Trimeresurus flavoviridis (Habu) (Asian Snakes list)
    31) Trimeresurus gracilis (Slender pit viper) (Asian Snakes list)
    32) Trimeresurus gramineus (Indian bamboo pit viper) (Asian Snakes list)
    33) Trimeresurus hageni (Hagen's pit viper) (Asian Snakes list)
    34) Trimeresurus huttoni (Hutton's pit viper) (Asian Snakes list)
    35) Trimeresurus jerdoni (Jerdon's pit viper) (Asian Snakes list)
    36) Trimeresurus kanburiensis (Kanchanaburi pit viper) (Asian Snakes list)
    37) Trimeresurus kaulbacki (Kaulback's pit viper) (Asian Snakes list)
    38) Trimeresurus labialis (Lipped pit viper) (Asian Snakes list)
    39) Trimeresurus macrolepis (Large-scaled pit viper) (Asian Snakes list)
    40) Trimeresurus macrops (Dark green pit viper) (Asian Snakes list)
    41) Trimeresurus malabarics (Malabar rock pit viper) (Asian Snakes list)
    42) Trimeresurus mangshannsis (Mount Mang pit viper) (Asian Snakes list)
    43) Trimeresurus medoenss (Medog pit viper) (Asian Snakes list)
    44) Trimeresurus mucrosuamatus (Chinese habu, Taiwan habu, or Taiwanese pit viper) (Asian Snakes list)
    45) Trimeresurus popeorum (Pope's pit viper) (Asian Snakes list)
    46) Trimeresurus punceus (Flat nosed-viper) (Asian Snakes list)
    47) Trimeresurus pupureomaculatus (Mangrove pit viper) (Asian Snakes list)
    48) Trimeresurus shultzei (Schultze's pit viper) (Asian Snakes list)
    49) Trimeresurus stejnegeri (Chinese bamboo pit viper or Green Habu) (Asian Snakes list)
    50) Trimeresurus strigatus (Horse-shoe pit viper) (Asian Snakes list)
    51) Trimeresurus sumatranus (Sumatran pit viper) (Asian Snakes list)
    52) Trimeresurus tibetanus (Tibetan pit viper) (Asian Snakes list)
    53) Trimeresurus tokarensis (Tokara-habu) (Asian Snakes list)
    54) Trimeresurus tonkinensis (Tonking pit viper) (Asian Snakes list)
    55) Trimeresurus trigonocephalus (Sri Lankan green pit viper) (Asian Snakes list)
    56) Trimeresurus xiangchengensis (Xiangcheng pit viper) (Asian Snakes list)
    57) Tropidolaemus wagleri (Wagler's viper or Temple pit viper) (Asian Snakes list)
    58) References: USDN, 1991; Meier & White, 1995
    VIPERIDAE (VIPERS AND PIT VIPERS, VIPERINAE)
    1) Azemiops faeae (Fea's viper) (Asian Snakes list)
    2) Cerastes gasperettii (Gasperetti's horned sand viper) (Asian Snakes list)
    3) Daboia russelii (Russell's viper or Daboia) (Asian Snakes list)
    4) Echis carinatus (Indian saw-scaled viper or Phoorsa) (Asian Snakes list)
    5) Echis multisquamatus (Central Asian saw-scaled viper) (Asian Snakes list)
    6) Echis sochureki (Sochurek's saw-scaled viper) (Asian Snakes list)
    7) Eristocophis mcmahoni (McMahon's viper) (Asian Snakes list)
    8) Pseudocerastes persicus (Persian horned viper) (Asian Snakes list)
    9) Vipera xanthina complex (Middle Eastern mountain viper) (Asian Snakes list)
    10) Vipera albicornuta (White-horned viper) (Asian Snakes list)
    11) Vipera latifii (Latifi's viper) (Asian Snakes list)
    12) Vipera raddei (Raddi's viper) (Asian Snakes list)
    13) Vipera russellii formosensis (Russell's pit viper) (Asian Snakes list)
    14) Vipera wagneri (Wagner's viper) (Asian Snakes list)
    15) Vipera xanthina (Ottoman viper) (Asian Snakes list)
    16) Vipera berus (European viper or Adder) (Asian Snakes list)
    17) Vipera lebetina (Levantine viper or Blunt-nosed viper) (Asian Snakes list)
    18) Vipera ursinii (Orsini's viper or Steppe viper) (Asian Snakes list)
    19) References: USDN, 1991; Meier & White, 1995

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) BACKGROUND: This management is limited to the discussion of Vipers of Asia and those species of most medical importance to this region. Please refer to the management ASIAN SNAKES-ELAPIDAE for further information regarding elapids of this region. Sea snakes will NOT be discussed here. Please refer to the SEA SNAKES management for further information.
    B) VIPERS: Vipers (family Viperidae) are venomous snakes which include 2 subfamilies: true vipers (Vipernae) and pit vipers (Crotalinae). Although these species are limited to a geographical area, bites from exotic species may occur outside their native region in reptile handlers, zoo personnel and amateur herpetologists.
    C) TOXICOLOGY: Venoms contain a wide variety of enzymes and proteins. Tissue necrosis is caused by proteolytic enzymes and phospholipases in venom. Procoagulants induce thrombin formation and depletion of clotting factors resulting in coagulopathy. Phospholipase A2 are believed to be responsible for neurotoxicity and rhabdomyolysis.
    D) EPIDEMIOLOGY: Several species of vipers, notably the Russell's viper (D. russelii), the mamushis (genus Agkistrodon (Gloydius)), the habus (genus Trimeresurus) and pit vipers (genera Calloselasma and Trimeresurus) can cause significant morbidity and mortality in endemic regions.
    E) WITH POISONING/EXPOSURE
    1) LOCAL TISSUE INJURY: Localized pain and swelling occur after envenomation by most species of vipers; localized bleeding is also relatively common and tissue necrosis can occur.
    2) COAGULOPATHY: Hemorrhagic effects, including thrombocytopenia, prolonged PT/INR and PTT, decreased fibrinogen levels and elevated fibrin split products, are produced by the venom of many vipers. Coagulopathy can result in bleeding from gums, wounds or venipuncture sites, hemoptysis, hematemesis, rectal bleeding, melena, hematuria, vaginal bleeding, and intracranial hemorrhage.
    3) SYSTEMIC EFFECTS: Other systemic effects can include: nausea, vomiting, hypotension, shock, disseminated intravascular coagulopathy, and hemolysis. The Daboia (Vipera russelii) is unique in that it is able to produce both hemorrhagic and neurotoxic effects. Acute renal failure and adrenal insufficiency have also been associated with D. russelii and some pit viper envenomations.
    4) ONSET: Immediate severe pain, erythema and swelling can occur after a bite. Generally, symptoms develop within 30 minutes of a pit viper envenomation. Venom can be rapidly absorbed and systemic effects (coagulopathy) can develop within 24 hours. In general, the later the onset of systemic symptoms the better the prognosis (ie, less venom absorbed).
    5) LONG-TERM EFFECTS: Bites can result in local tissue loss and necrosis which may require surgical debridement or amputation in some cases. Compartment syndrome is possible. Ongoing chronic ulceration, infection, osteomyelitis or arthritis may result in permanent disability. Chronic renal failure, chronic diabetes insipidus, or chronic neurologic injury as a result of intracranial hemorrhage are also reported.
    0.2.5) CARDIOVASCULAR
    A) WITH POISONING/EXPOSURE
    1) Cardiovascular toxicity may result in hypotension, shock and circulatory collapse and ECG abnormalities.
    0.2.7) NEUROLOGIC
    A) WITH POISONING/EXPOSURE
    1) Although neurotoxicity is more frequently associated with elapid exposure, it has occasionally been reported after daboia russelii bites. It primarily consists of cranial neuropathies; generalized flaccid paralysis and respiratory failure are rare.
    2) Permanent neurological damage may occur secondary to intracranial bleeding in patients with coagulopathy.
    0.2.8) GASTROINTESTINAL
    A) WITH POISONING/EXPOSURE
    1) Nausea, vomiting, or abdominal pain may develop after a bite. Intestinal necrosis has been reported infrequently following envenomation.
    0.2.12) FLUID-ELECTROLYTE
    A) WITH POISONING/EXPOSURE
    1) Hyperkalemia can occur as a result of acute renal failure and hypoglycemia may develop in the presence of adrenal/pituitary insufficiency.
    0.2.13) HEMATOLOGIC
    A) WITH POISONING/EXPOSURE
    1) Coagulopathy with thrombocytopenia, prolonged PT/INR and PTT, increased fibrin degradation products and decreased fibrinogen are common manifestations of moderate to severe envenomation. Localized and spontaneous systemic bleeding have been reported after viper bites.
    2) Intravascular hemolysis may occur with Russell's Viper envenomation.
    0.2.14) DERMATOLOGIC
    A) WITH POISONING/EXPOSURE
    1) Localized pain and swelling are reported after envenomation from most species, blebs and ecchymosis may be seen.
    2) Severe tissue injury resulting in necrosis, gangrene, compartment syndrome and permanent disability have developed.
    0.2.15) MUSCULOSKELETAL
    A) WITH POISONING/EXPOSURE
    1) Rhabdomyolysis and myoglobinurias have been associated with D. russelii bites.
    2) Compartment syndrome rarely develops after viper bites.
    0.2.20) REPRODUCTIVE
    A) Intrauterine demise has been reported after envenomation by an asian viper.
    B) Three pregnant women, bitten by Trimeresurus stejnegeri (Green Habu snake), developed pain and swelling at the bite site, and mild leukocytosis. Two of the three women received equine-derived hemotoxic bivalent F(ab')2 antivenom without the development of any adverse effects. All three women delivered healthy babies without any evidence of subsequent developmental delays.

Laboratory Monitoring

    A) The following tests should be obtained upon admission and repeated to assess worsening envenomation and/or efficacy of antivenom. Obtain complete blood count with differential. Monitor clotting factors (PT or INR, PTT) and platelet count. Repeat studies every 6 hours initially at least for 24 hours, then as indicated.
    B) The 20 minute Whole Blood Clotting Test (20WBCT) or may be referred to as the Whole Blood Clotting Test 20 (WBCT20) is a simple bedside test of coagulopathy and can be used instead of clotting factors (PT or INR, PTT) if clotting factors are not available.
    C) Obtain baseline urinalysis; observe for hematuria or proteinuria. Repeat as indicated.
    D) Obtain serum electrolytes, blood urea nitrogen, and creatinine daily or as indicated.
    E) Obtain a wound culture if there is evidence of a secondary infection.

Treatment Overview

    0.4.7) BITES/STINGS
    A) MANAGEMENT OF MILD TO MODERATE ENVENOMATION
    1) Management consists of local wound care, tetanus toxoid booster (if applicable), laboratory monitoring for coagulopathy, antivenom therapy in patients with evidence of envenomation and supportive care (including blood component infusions). The bullae of viper bite may be left intact; there is no need for incision or suction. Prophylactic antibiotics are not routinely recommended. Aspirin/Nonsteroidal antiinflammatory drugs (NSAIDs) should not be given in viper bites because of a theoretical bleeding risk.
    B) MANAGEMENT OF SEVERE ENVENOMATION
    1) Patients who develop severe toxicity should receive appropriate antivenom. Treat hypotension with IV fluids, if hypotension persists addition of vasopressors (eg, dopamine or norepinephrine) may be required. Necrotic tissue should be debrided and treated with broad spectrum antibiotics as needed. Patients with compartment syndrome should undergo fasciotomy. Before surgical intervention, all hemostatic abnormalities should be corrected. Patients with severe rhabdomyolysis with worsening renal function or hyperkalemia despite adequate hydration may require dialysis.
    C) DECONTAMINATION
    1) PREHOSPITAL CARE: The goal of prehospital care is to stabilize the patent and rapid transport to a healthcare facility. Pressure immobilization may delay venom absorption and should be utilized if it does not delay patient transport. Use an elastic stretchy crepe bandage (10 cm wide and at least 4.5 meters) or any long strip of material. Bound the bandage firmly around the entire bitten limb; start distally around the fingers or toes and move proximally to include a rigid splint. The bandage should be wrapped similar to a sprained ankle in which the wrap is snug, but does NOT occlude the peripheral pulses and a finger can be easily slipped between layers. CONTRAINDICATED: The following techniques or treatments are NOT recommended at the site of envenomation: cutting, burning, use of a tourniquet, electric shock or ice application. Theses methods are not helpful in delaying venom absorption and may cause local tissue injury.
    D) AIRWAY MANAGEMENT
    1) Rarely, patients with signs and symptoms of respiratory failure due to weakness secondary to neurotoxicity or rhabdomyolysis may need intubation for respiratory support.
    E) ANTIDOTE
    1) A variety of antivenoms are available.
    F) ANTIVENOMS
    1) INDICATION: Antivenom is indicated after a viper snake bite if the following effects are present: severe local effects, coagulation abnormalities (eg, spontaneous bleeding, laboratory evidence of coagulopathy), generalized rhabdomyolysis or neurotoxicity (eg, generally, limited to D. russelii). Administration of antivenom can reverse systemic envenomation effects even after several days; it will NOT be effective on local envenomation effects unless given within several hours after the bite. If the snake species is positively identified, administer a species specific antivenom when available. Regionally polyspecific antivenoms are appropriate when the snake species cannot be reliably identified or a species-specific antivenom is not available. Epinephrine, resuscitation equipment and proper monitoring must be prepared before administering antivenom.
    2) ADMINISTRATION: Antivenom should be reconstituted as directed in the package insert, diluted in 250 to 1000 mL of 0.9% saline and infused intravenously. Begin administration slowly with careful monitoring for allergic reactions and resuscitation equipment at the bedside. Gradually increase the rate of administration as tolerated. Local administration of antivenom at the site of the bite or intramuscular injection of antivenom is NOT recommended.
    3) RESPONSE: The effects of antivenom may require several hours; all supportive therapies should be maintained until clinical improvement is observed.
    4) SIDE EFFECTS: Acute allergic reaction, febrile reaction and serum sickness can occur. If an allergic reaction develops treat with epinephrine, antihistamines (H1 and H2) and corticosteroids. If the risk of envenomation outweighs the risk of further attempts at antivenom administration, consider resuming antivenom administration after further dilution in 0.9% saline at a slower rate of infusion, simultaneous infusion of epinephrine may be required. Consultation with a medical toxicologist is strongly recommended.
    5) ANTIVENOMS: See detailed treatment section for specific antivenoms.
    G) ENHANCED ELIMINATION
    1) Venom constituents are large molecules unlikely to be removed by hemodialysis or hemoperfusion.
    H) PATIENT DISPOSITION
    1) HOME CRITERIA: There is no role for home management of a suspected snake bite.
    2) OBSERVATION CRITERIA: Any patient who has been bitten by a proven or suspected venomous viper should be observed in a hospital for 24 hours. Observe for local complications and systemic toxicity (coagulopathy and acute renal injury). Because of the potential for delayed systemic toxicity, an asymptomatic patient with normal laboratory results after 24 hours of observation should be followed as an outpatient every 12 to 24 hours for 3 days.
    3) ADMISSION CRITERIA: Patients with evidence of local or systemic venom effects should be admitted for further treatment and monitoring for a treatment response and possible complications.
    4) CONSULT CRITERIA: Contact a medical toxicologist or local poison center for any patient with suspected viper envenomation. For patients with resulting acute renal failure and/or hyperkalemia due to rhabdomyolysis, consult a nephrologist for assistance with hemodialysis if needed.
    I) PITFALLS
    1) Failure to carefully monitor for progression of local effects or development of systemic venom effects. Failure to follow up patients with known exposure and initially normal laboratory values to evaluate for delayed-onset coagulopathy 24 to 72 hours after exposure. Failure to monitor for recurrence of systemic toxicity, patient should be monitored at least 48 hours after response to antivenom.
    J) DIFFERENTIAL DIAGNOSIS
    1) Anticoagulant toxicity, heparin induced thrombocytopenia, idiopathic thrombocytopenia purpura (ITP), disseminated intravascular coagulation (DIC), hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (ITP), necrotizing fasciitis, and compartment syndrome.

Range Of Toxicity

    A) TOXICITY: A viper bite does not always indicate that envenomation has occurred. However, "dry" bites can often result in envenomation. A single bite can result in severe envenomation or death.
    B) The family Viperidae which are represented by vipers, pit vipers and Viperinae (old world vipers) commonly produce severe localized pain and necrosis. Coagulopathies and hypotension can occur.
    C) Although NOT frequently reported, neurotoxicity can occur after envenomation by the Daboia russelii (Russell's Viper), and Chinese and Japanese Mamushis (A. b. brevicaudus and A. b. blomhoffii). The Daboia russelii can also produce acute renal failure, circulatory collapse, and rhabdomyolysis.
    D) Although these species are limited to a geographical area, bites from exotic species may occur outside their native region in reptile handlers, zoo personnel and amateur herpetologists.

Summary Of Exposure

    A) BACKGROUND: This management is limited to the discussion of Vipers of Asia and those species of most medical importance to this region. Please refer to the management ASIAN SNAKES-ELAPIDAE for further information regarding elapids of this region. Sea snakes will NOT be discussed here. Please refer to the SEA SNAKES management for further information.
    B) VIPERS: Vipers (family Viperidae) are venomous snakes which include 2 subfamilies: true vipers (Vipernae) and pit vipers (Crotalinae). Although these species are limited to a geographical area, bites from exotic species may occur outside their native region in reptile handlers, zoo personnel and amateur herpetologists.
    C) TOXICOLOGY: Venoms contain a wide variety of enzymes and proteins. Tissue necrosis is caused by proteolytic enzymes and phospholipases in venom. Procoagulants induce thrombin formation and depletion of clotting factors resulting in coagulopathy. Phospholipase A2 are believed to be responsible for neurotoxicity and rhabdomyolysis.
    D) EPIDEMIOLOGY: Several species of vipers, notably the Russell's viper (D. russelii), the mamushis (genus Agkistrodon (Gloydius)), the habus (genus Trimeresurus) and pit vipers (genera Calloselasma and Trimeresurus) can cause significant morbidity and mortality in endemic regions.
    E) WITH POISONING/EXPOSURE
    1) LOCAL TISSUE INJURY: Localized pain and swelling occur after envenomation by most species of vipers; localized bleeding is also relatively common and tissue necrosis can occur.
    2) COAGULOPATHY: Hemorrhagic effects, including thrombocytopenia, prolonged PT/INR and PTT, decreased fibrinogen levels and elevated fibrin split products, are produced by the venom of many vipers. Coagulopathy can result in bleeding from gums, wounds or venipuncture sites, hemoptysis, hematemesis, rectal bleeding, melena, hematuria, vaginal bleeding, and intracranial hemorrhage.
    3) SYSTEMIC EFFECTS: Other systemic effects can include: nausea, vomiting, hypotension, shock, disseminated intravascular coagulopathy, and hemolysis. The Daboia (Vipera russelii) is unique in that it is able to produce both hemorrhagic and neurotoxic effects. Acute renal failure and adrenal insufficiency have also been associated with D. russelii and some pit viper envenomations.
    4) ONSET: Immediate severe pain, erythema and swelling can occur after a bite. Generally, symptoms develop within 30 minutes of a pit viper envenomation. Venom can be rapidly absorbed and systemic effects (coagulopathy) can develop within 24 hours. In general, the later the onset of systemic symptoms the better the prognosis (ie, less venom absorbed).
    5) LONG-TERM EFFECTS: Bites can result in local tissue loss and necrosis which may require surgical debridement or amputation in some cases. Compartment syndrome is possible. Ongoing chronic ulceration, infection, osteomyelitis or arthritis may result in permanent disability. Chronic renal failure, chronic diabetes insipidus, or chronic neurologic injury as a result of intracranial hemorrhage are also reported.

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) CASE REPORT: A 34-year-old man was bitten by a Deinagkistrodon acutus (formerly Agkistrodon actus) in the eye, and developed no light perception in that eye. At 4.5 hours after exposure, effects included: periorbital ecchymoses, facial edema, massive subconjunctival hemorrhage, severe corneal edema, and exophthalmos of the right eye. The patient was intubated for progressive facial edema and airway management and received 2 vials of D. acutus antivenom. Six hours after exposure, the eye continued to bleed and necrosis of the surrounding conjunctiva, Tenon capsule, episclera, and sclera were observed; treatment consisted of evisceration of the eye to minimize the effects of the venom (Chen et al, 2005).
    2) CASE REPORT: Bilateral ptosis and angioedema of the eyelid, without vision loss, were reported in a 31-year-old man following envenomation by Eristicophis macmahonii (Asian sand viper). The patient recovered with supportive therapy, including administration of antihistamines and IV steroids (denEndenErwin & Emmanuel, 2005).

Cardiovascular

    3.5.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Cardiovascular toxicity may result in hypotension, shock and circulatory collapse and ECG abnormalities.
    3.5.2) CLINICAL EFFECTS
    A) HYPOTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) Systemic envenomation by Daboia russelii (Russell's Viper) can produce a complex of clinical symptoms which includes hypotension (Than et al, 1991; Swe et al, 1997).
    b) FATALITIES: Hypotension has been responsible for 38% of deaths related to D. russelii envenomation (Swe et al, 1997).
    c) PATHOLOGY: Alterations in blood cortisol concentrations may have a role in producing hypotension. Steroid therapy (given at the onset of hypotension) appeared to be effective in stabilizing 3 patients with hypotension after D. russelii envenomation (Swe et al, 1997).
    B) SHOCK
    1) WITH POISONING/EXPOSURE
    a) D. russelii: Circulatory shock can occur after a D. russelii bite. Early symptoms may be related to vasodilatation with decreased peripheral vascular resistance. Persistent symptoms may then result from ongoing hemorrhage and massive necrosis of the pituitary and/or adrenal glands (Swe et al, 1997).
    C) TAKOTSUBO CARDIOMYOPATHY
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Stress-induced cardiomyopathy (ie transient left ventricular apical ballooning syndrome) was reported in a 56-year-old woman after being bitten by a presumed Gloydius blomhoffi on her foot. An ECG showed negative T waves in various leads and an echocardiogram was performed showing abnormal left ventricular systolic function with apical akinesis and a hyperdynamic basal segment of the left ventricle. Hemodynamic abnormalities or arrhythmias did not develop. By day 4, the ECG and echocardiogram were both normal (Murase & Takagi, 2012).
    D) ELECTROCARDIOGRAM ABNORMAL
    1) WITH POISONING/EXPOSURE
    a) SUMMARY: Envenomation by some vipers can result in direct myocardial toxicity as noted by cardiac dysrhythmias or abnormal ECG findings (Meier & White, 1995).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) RESPIRATORY FAILURE
    1) WITH POISONING/EXPOSURE
    a) Although respiratory insufficiency is NOT usually a characteristic of a viper envenomation, D. russelii (Russell's Viper) envenomation can rarely result in respiratory and generalized flaccid paralysis (Anon, 1999).
    B) DYSPNEA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Dyspnea without bronchospasms was reported in a 31-year-old man following envenomation by an Asian sand viper (Eristicophis macmahonii) (denEndenErwin & Emmanuel, 2005).

Neurologic

    3.7.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Although neurotoxicity is more frequently associated with elapid exposure, it has occasionally been reported after daboia russelii bites. It primarily consists of cranial neuropathies; generalized flaccid paralysis and respiratory failure are rare.
    2) Permanent neurological damage may occur secondary to intracranial bleeding in patients with coagulopathy.
    3.7.2) CLINICAL EFFECTS
    A) CEREBRAL HEMORRHAGE
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Facial palsy, generalized paralysis and coma may occur secondary to cerebral hemorrhage in patients with severe coagulopathies (Kuo & Wu, 1972; Anon, 1999).
    b) CASE REPORTS
    1) Deteriorated mental function, facial palsy and paralysis were thought to be secondary to cerebral hemorrhage in a 41-year-old female bitten by a T. mucrosquamatus (Chinese Habu). The patient responded well to symptomatic care and physical therapy (Kuo & Wu, 1972).
    2) Viper bites with coagulopathy have resulted in fatal cerebral hemorrhage. Two adults died after a bite by a D. russelii (Russell's Viper) and a T. albolabris; one patient developed frontal and subarachnoid hemorrhage, while the other had a fatal cerebrovascular accident despite supportive care (Cockram et al, 1990).
    3) A 24-year-old woman experienced a severe headache approximately 7 hours after being bitten on her left foot by Echis sochureki (saw-scaled viper). Fourteen hours post-envenomation the patient became comatose with mydriasis of the right eye and complete hemiplegia on her left side. A 20-minute whole blood clotting test (20-WBCT) showed incoagulability of her blood and a CT scan showed the presence of a subdural hematoma. Treatment consisted of continuous intravenous infusion of polyvalent antivenom (total number of vials given=16). A repeat 20-WBCT, performed 6 hours after the first clotting test, showed coagulable blood. Following fronto-temporal burr hole placement and removal of approximately 100 mL of clot, the patient's condition gradually improved and she was subsequently discharged 20 days post-envenomation with moderate residual weakness of the left side of her body (Kochar et al, 2007).
    B) CEREBRAL INFARCTION
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 55-year-old man was bitten on the toe by a Russell's viper and developed coagulopathy (initial clotting time was more than an hour). Ten vials of equine polyvalent antisnake venin (ASV) was given along with other wound care and prophylactic parenteral ampicillin and metronidazole. An additional, 16 vials of ASV was given over the next 8 hours. The following day, his coagulation studies were normal but he continued to have a prolonged clotting time and remained drowsy. An intracranial bleed was suspected due to ongoing disorientation, restlessness and prolonged clotting time. A MRI of the brain showed bilateral thalamic infarcts. Gradually, over the next week he clinically improved and his neurologic function returned to normal. He continued to do well 6 months later (Ittyachen & Jose, 2012).
    C) CENTRAL NERVOUS SYSTEM FINDING
    1) WITH POISONING/EXPOSURE
    a) Sleepiness and dizziness have been reported after a bite by a Daboia (Vipera) russelii and a T. mucrosquamatus (Chinese Habu) (Kuo & Wu, 1972).
    D) PARALYSIS
    1) WITH POISONING/EXPOSURE
    a) Generalized flaccid paralysis can develop after envenomation by a D. russelii (Russell's Viper) (Anon, 1999). Muscle paralysis, however, is NOT a characteristic of other viper envenomations.
    E) PARESTHESIA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 31-year-old man was bitten by Eristicophis macmahonii (Asian sand viper) on the tip of the third finger of his left hand, and subsequently developed paresthesias in his contralateral arm and fingers. The patient also experienced a skin rash, edema, generalized tremors, muscular weakness, dyspnea, dysphagia, dry mouth, and bilateral ptosis. The patient recovered following supportive care (denEndenErwin & Emmanuel, 2005).
    F) HEADACHE
    1) WITH POISONING/EXPOSURE
    a) Headaches were reported following envenomation by H. hypnale (hump-nosed pit viper) and Echis sochureki (saw-scaled viper) (Joseph et al, 2007; Kochar et al, 2007).

Gastrointestinal

    3.8.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Nausea, vomiting, or abdominal pain may develop after a bite. Intestinal necrosis has been reported infrequently following envenomation.
    3.8.2) CLINICAL EFFECTS
    A) NAUSEA AND VOMITING
    1) WITH POISONING/EXPOSURE
    a) Generalized symptoms of nausea, vomiting or abdominal pain may be present after a viper envenomation (Joseph et al, 2007; denEndenErwin & Emmanuel, 2005; Anon, 1999).
    b) INCIDENCE: Vomiting occurred in 11 of 12 patients following envenomation by Echis sochureki (saw-scaled viper) (Kochar et al, 2007).
    B) COLITIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT
    1) A 57-year-old man was bitten by an Agkistrodon blomhoffii (Japanese Mamushi) and initially developed severe abdominal pain, frequent tarry stools and abdominal distension. The patient's hospital course was complicated by disseminated intravascular coagulation (DIC) and acute renal failure. It has been suggested that DIC may have been responsible for gastrointestinal tract occlusion of small vessels which produces intestinal necrosis. On day 125, stenotic lesions of the descending colon were resected and a right hemicolectomy performed; histologic evidence of ischemic colitis was present. The patient recovered, and 12 months later he remained asymptomatic (Iwakiri et al, 1995).
    C) APTYALISM
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A very dry mouth and dysphagia were reported in a 31-year-old man who was bitten by an Asian sand viper (Eristicophis macmahonii) (denEndenErwin & Emmanuel, 2005).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) ACUTE RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) SUMMARY: Acute renal failure requiring dialysis (peritoneal or hemodialysis) has been reported after bites by vipers (e.g., Agkistrodon blomhoffii {pit viper}, A. halys {pit viper}, Daboia russelii, H. hypnale {pit viper}) (Joseph et al, 2007; Swe et al, 1997; Iwakiri et al, 1995; Than et al, 1991; Moore, 1977) .
    a) Acute renal failure is often associated with the presence of DIC which results in severe renal tubular and cortical necrosis with widespread microvascular fibrin deposition (microthrombi). It is suggested, however, that a direct toxic effect produced by the venom of D. russelii (Russell's Viper) may produce renal damage (Aung et al, 1998).
    b) Moore (1977) reported that acute renal failure developed in two patients without DIC or circulatory shock; it was suggested that renal failure were caused by myoglobinuria and possibly due to the direct effects of the venom.
    2) According to a retrospective analysis of snakebites admitted to a hospital in northwest India during January of 1997 to December of 2001, acute renal failure was reported in 39 of 52 patients (75%) following viper envenomations, with 33 of the 39 patients (84.6%) requiring dialysis (Sharma et al, 2005).
    b) DABOIA RUSSELII
    1) INCIDENCE: In a case series of 24 patients with systemic envenomation, 10 patients developed mild renal dysfunction, but recovered with antivenom treatment alone. Of 5 patients who had developed oliguric acute renal failure, peritoneal dialysis was required.
    2) FATALITIES: Oliguric acute renal failure is responsible for 44% of deaths related to envenomation (Swe et al, 1997) and is the most common cause of death in D. russelii (Russell's Viper) envenomations (Aung et al, 1998).
    3) PATHOLOGY: The acute renal failure which can develop resembles that of acute tubular necrosis. The onset of renal damage may begin within several hours of a bite with onset noted by the presence of proteinuria, and the possible disruption of urine flow. The authors have suggested that the administration of antivenom does NOT alter the course of severe renal damage; therefore, the treatment of choice is dialysis which corrects the underlying pathology: acute reversible tubular necrosis (Than et al, 1991).
    4) ANTIVENOM: A study was performed comparing 12 patients with Russel's viper envenomation who received antivenom early (within 6 hours of bite) with 19 historic controls who received late or no antivenom. Six of the 12 cases who received early antivenom treatment developed acute renal failure (50%) as compared to 14 of the 19 cases who received either late or no antivenom treatment (73.7%). The severity of renal failure was less in patients who were given early antivenom treatment as compared with late or no antivenom treatment (hemodialysis needed: 2 (16.7%) vs 10 (52.6%), respectively). This suggests that early intervention with antivenom treatment MAY impact renal function after envenomation, but the use of historic controls precludes confidence in this conclusion (Hung et al, 2006).
    c) HYPNALE HYPNALE
    1) CASE REPORT: A 54-year-old man experienced decreased urine output approximately 22 hours after being bitten by Hypnale hypnale (hump-nosed pit viper). Laboratory analysis revealed elevated serum creatinine and BUN concentrations, peaking at 7 mg/dL and 110 mg/dL, respectively, and urinalysis showed proteinuria. The patient's renal function improved, with his serum creatinine level decreasing to 2 mg/dL, after receiving 15 sessions of alternate day hemodialysis (Joseph et al, 2007).

Hematologic

    3.13.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Coagulopathy with thrombocytopenia, prolonged PT/INR and PTT, increased fibrin degradation products and decreased fibrinogen are common manifestations of moderate to severe envenomation. Localized and spontaneous systemic bleeding have been reported after viper bites.
    2) Intravascular hemolysis may occur with Russell's Viper envenomation.
    3.13.2) CLINICAL EFFECTS
    A) BLOOD COAGULATION PATHWAY FINDING
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Disseminated intravascular coagulation (DIC) may develop after viper envenomation (Sharma et al, 2005; Anon, 1999). Disorders of platelet aggregation and the coagulation-fibrinolysis system have been observed in patients with snakebites from Daboia (Vipera) russelii, genus Trimeresurus, and the Agkistrodon blomhoffii and A. halys species (Chan et al, 1993; Chan et al, 1993a) (Iwarkiri et al, 1995)(Li et al, 2000).
    2) Coagulation disorders produced by vipers are promptly reversed by antivenom administration (Rojnuckarin et al, 1998; Hung et al, 2006).
    b) PREDICTORS: T. albolabris and T. macrops (green pit vipers): Systemic bleeding was found to occur more often if the bite occurred at a site other than the fingers or toes (venom NOT well absorbed from the digits); a requirement for antivenom within 24 hours, and prolonged venous clotting time and thrombocytopenia (Rojnuckarin et al, 1998).
    c) SEVERITY: Serious morbidity and mortality may result from the development of DIC. Fatalities have been reported secondary to the hemorrhagic effects of a viper envenomation (Kuo & Wu, 1972).
    d) INCIDENCE
    1) In a national hospital-based survey of snake bites in Thailand, the following clinical features related to hematological disorders were reported (Viravan et al, 1992):
    a) Calloselasma rhodostoma (Malayan Pit Viper): Incoagulable blood was reported in 57 (38.8%) of 147 cases;
    b) T. albolabris: Incoagulable blood in 13 (20.6%) of 63 cases;
    c) D. russelii: Incoagulable blood in 19 (27.9%) of 68 cases.
    2) E. SOCHUREKI: Incoagulable blood was reported in all 12 patients bitten by Echis sochureki (saw-scaled viper) in Rajasthan, India (Kochar et al, 2007).
    3) H. HYPNALE: Incoagulable blood was reported in patients approximately 12 to 24 hours following envenomation by Hypnale hypnale (hump-nose pit viper) (Joseph et al, 2007).
    e) CASE REPORTS
    1) A patient developed DIC after a bite by a A. blomhoffii (Japanese Mamushi), which resulted in the development of renal cortical necrosis and ischemic injury to the colon resulting in bowel resection (Iwarkiri et al, 1995).
    2) Defibrination (prolonged clotting time greater than 30 minutes) occurred in a 27-year-old man who was bitten by a snake suspected to be from the Viperidae family. Despite receiving a total of 30 units of antivenom (300 mL) over a 6-day period, the patient's clotting time continued to be greater than 30 minutes and his prothrombin time was more than 1 minute; however, there was no evidence of bleeding from any site. On the 7th day post-envenomation, the patient's clotting time returned to normal and the patient was subsequently discharged (Jacob, 2006). The authors speculate that the continued defibrination may have been either due to unneutralized venom components or that, even though the snake was believed to be from the Viperidae family, the antivenom used was not specific for that particular species of snake.
    f) CASE SERIES
    1) In a series of 21 cases of envenomation by T. albolabris, 86% (n=18) of the victims had increased blood concentrations of fibrin degradation products (FDP) ranging from 10 to 40 mcg/L (normal: less than 10 mcg/L) and 28% (n=10) had thrombocytopenia or prolonged prothrombin time (PT), activated partial thromboplastin time (APTT) and thrombin time (TT). No patient in this study received antivenom and coagulation abnormalities were corrected with replacement therapy (i.e., platelet transfusions and fresh frozen plasma) (Chan et al, 1993a).
    B) THROMBOCYTOPENIC DISORDER
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Thrombocytopenia has developed after viper envenomation (Joseph et al, 2007; Kochar et al, 2007; Hung et al, 2006; Rojnuckarin et al, 1998; Chan et al, 1993) .
    b) CASE SERIES
    1) In a review of 242 cases of venomous snakebites, of those who developed hematologic abnormalities (10% (n=24)), thrombocytopenia was the most common abnormality reported along with excessive fibrinolysis and defibrination (Cockram et al, 1990).
    2) In a retrospective study of 30 patients with green pit viper envenomation, platelet counts and mean platelet volume were lower in envenomated patients than control subjects (Soogarun et al, 2003).
    C) COAG./BLEEDING TESTS ABNORMAL
    1) WITH POISONING/EXPOSURE
    a) CASE REPORTS
    1) Prolonged bleeding, oozing (more than 24 hours) and ecchymosis have been reported after viper bites (e.g., Agkistrodon acutus, Japanese Mamushi, and genus Trimeresurus {T. albolabris, T. macrops}) (Kuo & Wu, 1972; Hutton et al, 1990).
    2) Severe coagulopathy (PT >60 seconds, INR >4.5, APTT >150 seconds) was reported in a 6-year-old girl 4 days after being bitten by T. albolabris (white-lipped green pit viper). Initially, the patient had been given Agkistrodon halys antivenin with no clinical improvement; however the coagulopathy completely resolved within 2 days after receiving 5 vials of Green Pit Viper antivenin (Yang et al, 2007).
    b) INCIDENCE
    1) Of 29 patients with snakebites by T. albolabris or T. macrops, 58% of patients developed localized bruising (Hutton et al, 1990).
    D) BLEEDING
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Hematological effects can result in bleeding from multiple sites (e.g., bleeding gums, hemoptysis, hematemesis, rectal bleeding, melena, hematuria, vaginal bleeding, old wound sites or venipuncture sites) (Kochar et al, 2007; Sharma et al, 2005; Anon, 1999). Evidence of generalized petechial hemorrhage may be noted (Buranasin, 1993).
    b) INCIDENCE
    1) TRIMERESURUS
    a) In a case series of 72 victims of Trimeresurus sp. bites, 52 cases developed only localized symptoms while coagulopathies were reported in 25 victims (34.7%). Of those 25 victims, 7 showed evidence of systemic bleeding (i.e., hematemesis, hematuria, bleeding gums, and generalized petechial hemorrhage). In all cases, hematologic disturbances resolved within 5 to 6 hours after antivenom administration (Buranasin, 1993).
    b) T. albolabris or T. macrops (Green Pit Vipers): Of 271 moderate to severely envenomated patients, 17.3% developed systemic bleeding (Rojnuckarin et al, 1998).
    2) E. SOCHUREKI
    a) E. SOCHUREKI: Systemic bleeding was reported in 7 of 12 patients following envenomation by Echis sochureki (saw-scaled viper) (Kochar et al, 2007).
    c) CASE REPORTS
    1) AGKISTRODON ACUTUS
    a) PEDIATRIC: A 10-year-old girl developed bleeding from the nose, gingiva, eponychium and other abrasion sites approximately 24 hours after envenomation. Anemia was present (Hgb 7.93 grams/dL), along with hematuria. Bleeding time was prolonged greater than 1 hour without clotting. The patient responded to antivenom therapy; oozing from local wound sites stopped within 12 hours. Symptomatic care also included a blood transfusion (Kuo & Wu, 1972).
    E) LEUKOCYTOSIS
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Leukocytosis may occur after viper envenomation. Bites by the following species have resulted in leukocytosis: A. acutus (Japanese Mamushi) T. albolabris (White-lipped Green Pit Viper) and T. stejnegeri (Green Habu) (Chen et al, 2007; Chan et al, 1993; Kuo & Wu, 1972).
    b) INCIDENCE
    1) T. albolabris: Of 30 patients envenomated, 8 developed leukocytosis (Chan et al, 1993).
    F) HEMOLYSIS
    1) WITH POISONING/EXPOSURE
    a) Hemolysis has been reported following Russell's viper (D. russelli siamensis) envenomations (Hung et al, 2006).

Dermatologic

    3.14.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Localized pain and swelling are reported after envenomation from most species, blebs and ecchymosis may be seen.
    2) Severe tissue injury resulting in necrosis, gangrene, compartment syndrome and permanent disability have developed.
    3.14.2) CLINICAL EFFECTS
    A) EDEMA
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Swelling and erythema are likely to occur following any viper envenomation (Anon, 1999) (Warrell et al, 1992) (Kuo & Wu, 1972). Swelling may progress and involve the entire affected limb and include the regional lymphatic system (denEndenErwin & Emmanuel, 2005; Meier & White, 1995). In one case report, envenomation by a juvenile A. rhodostoma (Pit Viper) produced only local swelling and erythema; no systemic effects were reported (Vest & Kardong, 1980).
    b) LOCALIZED EFFECTS
    1) A. rhodostoma: A bite by a juvenile pit viper (A. rhodostoma) produced swelling in the affected hand and arm which began to resolve within 12 hours of the bite. The authors suggested that the relatively minor side effects were due to the limited quantity of venom available which was NOT sufficient to produce systemic envenomation (Vest & Kardong, 1980).
    2) In a national hospital-based survey of snakebites in Thailand, bites from T. macrops, T. purpureomaculatus, T. wagleri caused only mild local swelling and no serious systemic effects (Viravan et al, 1992).
    3) Pain and localized swelling were reported in 11 of 12 patients who were bitten by E. sochureki (Kochar et al, 2007) and in 5 patients following envenomation by H. hypnale (hump-nosed pit viper) (Joseph et al, 2007).
    c) REGIONAL EFFECTS
    1) Of 29 patients with snakebites by T. albolabris or T. macrops, swelling spread to include greater than half the bitten limb in 46% of patients and 46% of patients developed tender enlargement of local lymph nodes (Hutton et al, 1990).
    2) CASE REPORT: A 6-year-old child, who was bitten on her right foot by Trimeresurus albolabris (white-lipped green pit viper), developed swelling of her right foot that progressed to her knee over the next 12 hours. Within 24 hours, the swelling had progressed to her mid thigh, and blisters had developed near the site of the bite (Yang et al, 2007).
    3) CASE REPORT: A 25-year-old woman developed swelling which spread from the foot to the ankle area within 30 minutes of being bitten by a T. kanburiensis. Within 2 hours, edema had spread to the mid calf area and, 24 hours after exposure it had reached the mid thigh area; eventually it extended into the flank area. The patient was treated symptomatically, and was discharged 4 days after the bite with no evidence of permanent sequelae (Warrell et al, 1992).
    B) PAIN
    1) WITH POISONING/EXPOSURE
    a) SUMMARY: Envenomation by vipers usually produces immediate pain (Warrell et al, 1992) (Chan et al, 1993; Anon, 1999; Jacob, 2006). A juvenile bite by a pit viper produced throbbing pain, but the duration of symptoms was less than would be expected following an adult envenomation (Vest & Kardong, 1980).
    b) INCIDENCE
    1) T. ALBOLABRIS: In a case series of 31 victims of a Trimeresurus albolabris bite, all patients developed pain and swelling (Chan et al, 1993).
    2) Pain and localized swelling were reported in 11 of 12 patients who were bitten by E. sochureki (Kochar et al, 2007) and in 5 patients following envenomation by H. hypnale (hump-nosed pit viper) (Joseph et al, 2007).
    C) BLISTERING ERUPTION
    1) WITH POISONING/EXPOSURE
    a) Local blistering may occur after viper envenomation. The presence of blisters is more likely to lead to necrosis and/or secondary infections in bites by T. albolabris or T. macrops (Green Pit Vipers) (Yang et al, 2007; Rojnuckarin et al, 1998).
    b) INCIDENCE
    1) Of 29 patients with snakebites by T. albolabris or T. macrops, 6 patients developed localized blistering (Hutton et al, 1990).
    2) Blistering occurred in 3 of 12 patients following envenomation by E. sochureki (Kochar et al, 2007).
    D) SKIN NECROSIS
    1) WITH POISONING/EXPOSURE
    a) Tissue necrosis can occur after viper envenomation (Hutton et al, 1990; denEndenErwin & Emmanuel, 2005). Necrosis was more likely to develop after bites sustained on fingers or toes by T. albolabris or T. macrops (Green Pit Vipers), due to poor systemic absorption of the venom (resulting in a higher concentration of localized venom) (Rojnuckarin et al, 1998).
    b) INCIDENCE
    1) T. albolabris or T. macrops (Green Pit Vipers): Of 271 moderately to severely envenomated patients, 6.6% developed wound necrosis (Rojnuckarin et al, 1998).
    2) Necrosis occurred in 2 of 12 patients following envenomation by E. sochureki (Kochar et al, 2007).
    E) LOCAL INFECTION OF WOUND
    1) WITH POISONING/EXPOSURE
    a) Localized infection can occur after viper envenomation.
    b) INCIDENCE
    1) T. albolabris or T. macrops (Green Pit Vipers) - Of 271 moderately to severely envenomated patients, 5.5% developed secondary infection (Rojnuckarin et al, 1998).
    F) ERUPTION
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A burning skin rash occurred in a 31-year-old man who was bitten by an Asian sand viper (Eristicophis macmahonii). The rash resolved with supportive treatment, including administration of antihistamines and IV steroids (denEndenErwin & Emmanuel, 2005).

Musculoskeletal

    3.15.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Rhabdomyolysis and myoglobinurias have been associated with D. russelii bites.
    2) Compartment syndrome rarely develops after viper bites.
    3.15.2) CLINICAL EFFECTS
    A) RHABDOMYOLYSIS
    1) WITH POISONING/EXPOSURE
    a) Rhabdomyolysis and myoglobinuria can develop after D. russelii (Russell's Viper) envenomation (Hung et al, 2006; Anon, 1999).
    B) COMPARTMENT SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Severe local envenomation can result in severe swelling and local necrosis and, if left untreated, may progress to compartment syndromes, which is more likely to occur if a patient can NOT be treated with antivenom (Anon, 1999).
    C) OSTEOMYELITIS
    1) WITH POISONING/EXPOSURE
    a) SUMMARY: Chronic osteomyelitis or arthritis may occur after an intraarticular viper envenomation (Anon, 1999).
    1) CASE REPORT: A reptile handler developed osteomyelitis, and intraoperatively was found to have complete joint erosion of the proximal interphalangeal joint after envenomation by a T. flavomaculatus. Permanent joint immobility and intermittent pain was reported up to 16 months after the bite (Clark & Davidson, 1997).

Endocrine

    3.16.2) CLINICAL EFFECTS
    A) ADRENAL CORTICAL HYPOFUNCTION
    1) WITH POISONING/EXPOSURE
    a) D. RUSSELII: Bites by Russell's Vipers are able to produce acute adrenal/pituitary insufficiency which can result in clinical symptoms of shock and hypoglycemia (Anon, 1999).
    B) HYPOPITUITARISM
    1) WITH POISONING/EXPOSURE
    a) SUMMARY
    1) Acute and chronic hypopituitarism has been reported following a Russell's viper bite (Antonypillai et al, 2011).
    b) PERSISTENT TOXICITY
    1) A chronic phase that can occur months to years after a bite by a Russell's Viper can produce weakness, loss of secondary sexual hair, amenorrhea, testicular atrophy, and hypothyroidism (Anon, 1999).
    2) CASE REPORT: A 49-year-old man from Sri Lanka was bitten by a Russel's viper on his left foot and developed acute symptoms of vomiting, blurred vision and coagulopathy within the first few hours. He was treated with Haffkine polyvalent anti-venom and required treatment for an early anaphylactic reaction but was discharged 2 days later. However, the patient continued to have persistent symptoms of fatigue, weakness, and reduced libido up to 3 years after envenomation. Pituitary function studies revealed steroid thyroid and gonadal axes deficiencies. Following treatment with hydrocortisone, levothyroxine and testosterone he was clinically improved 1 month later (Antonypillai et al, 2011).
    3) PATHOGENESIS: Russell's viper envenomation can lead to acute and chronic hypopituitarism. It may be the result of focal hemorrhage and micro vascular thrombin deposition in the pituitary leading to hemorrhagic infarction of the anterior pituitary leading to acute and chronic pan-hypopituitarism (Antonypillai et al, 2011).
    4) DIAGNOSIS: Chronic hypopituitarism can be diagnosed by the following studies: dynamic pituitary function tests, including insulin tolerance test, thyrotropin-releasing hormone stimulation test and luteinizing hormone-releasing hormone stimulation test (Antonypillai et al, 2011).
    5) ONSET: In a study of 24 patients in Burma with a Russell's viper envenomation, the diagnosis of chronic hypopituitarism occurred within 6 months to 4 years after evenomation; symptoms developed as early as 4 weeks in some patients (Antonypillai et al, 2011).
    C) HYPOGLYCEMIA
    1) WITH POISONING/EXPOSURE
    a) Hypoglycemia may occur as a result of adrenal/pituitary insufficiency following a D. russelii (Russell's Viper) envenomation (Anon, 1999).

Reproductive

    3.20.1) SUMMARY
    A) Intrauterine demise has been reported after envenomation by an asian viper.
    B) Three pregnant women, bitten by Trimeresurus stejnegeri (Green Habu snake), developed pain and swelling at the bite site, and mild leukocytosis. Two of the three women received equine-derived hemotoxic bivalent F(ab')2 antivenom without the development of any adverse effects. All three women delivered healthy babies without any evidence of subsequent developmental delays.
    3.20.3) EFFECTS IN PREGNANCY
    A) INTRAUTERINE FETAL DEATH
    1) CASE REPORT - A 29-year-old woman who was 10 weeks pregnant was bitten by a viper (A. halys blomhoffii, mamushi) and developed swelling, mild rhabdomyolysis and paralysis of the right oculomotor nerve. One week prior to the bite, ultrasound had shown a live fetus. One week after exposure, ultrasound showed loss of the fetal heart beat and the woman underwent a D&C(Nasu et al, 2004).
    B) LACK OF EFFECT
    1) CASE SERIES - Three pregnant women, in various stages of pregnancy (ranging from 8 weeks to 28 weeks gestation), were bitten by Trimeresurus stejnegeri (Green Habu snake). All three women developed localized symptoms in the region of the envenomation site (pain, bleeding, swelling, ecchymosis) and mild leukocytosis. Two of the three women were given equine derived hemotoxic bivalent F(ab')2 antivenom without development of adverse effects. All 3 women recovered without sequelae and subsequently delivered healthy babies. Follow-up of the children, several years later, showed no developmental delays (Chen et al, 2007).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) The following tests should be obtained upon admission and repeated to assess worsening envenomation and/or efficacy of antivenom. Obtain complete blood count with differential. Monitor clotting factors (PT or INR, PTT) and platelet count. Repeat studies every 6 hours initially at least for 24 hours, then as indicated.
    B) The 20 minute Whole Blood Clotting Test (20WBCT) or may be referred to as the Whole Blood Clotting Test 20 (WBCT20) is a simple bedside test of coagulopathy and can be used instead of clotting factors (PT or INR, PTT) if clotting factors are not available.
    C) Obtain baseline urinalysis; observe for hematuria or proteinuria. Repeat as indicated.
    D) Obtain serum electrolytes, blood urea nitrogen, and creatinine daily or as indicated.
    E) Obtain a wound culture if there is evidence of a secondary infection.
    4.1.2) SERUM/BLOOD
    A) HEMATOLOGIC
    1) Obtain a complete blood count with differential. A coagulation profile which includes INR/PT and PTT, platelet count, fibrinogen level and fibrin degradation products should be obtained after a viper envenomation. Repeat every 6 hours or as indicated to assess for progression of envenomation or response to antivenom.
    2) An early neutrophil leucocytosis can be evident of systemic envenoming from any species (Warrell, 2010).
    B) BLOOD/SERUM CHEMISTRY
    1) Monitor serum electrolytes, blood urea nitrogen, and creatinine as indicated.
    2) Obtain creatine kinase in patients with severe swelling or evidence of compartment syndrome.
    3) Monitor serum cortisol levels in patients envenomated by a daboia russelii (Russell's Viper). Alterations in pituitary and/or adrenal function have been documented.
    4.1.3) URINE
    A) URINALYSIS
    1) Obtain urinalysis. Monitor for evidence of bleeding (hematuria {urine may be pink, red, brown or black) (Warrell, 2010) or acute renal failure (proteinuria). Creatinine clearance may be indicated in patients with increased serum creatinine daboia russelii (Russell's viper) envenomation.
    2) Urinary NAG: The urinary enzyme, beta-N-acetylglucosaminidase (N-acetyl-beta-delta-glucosaminidase; NAG) has been used to obtain early diagnosis of renal damage after D. russelii bite (Aung et al, 1998). Elevations in urinary NAG levels are both sensitive and specific for detecting early renal damage.
    3) Monitor urine output; oliguria has been reported.
    4.1.4) OTHER
    A) OTHER
    1) CULTURES
    a) Obtain wound culture in necrotic wounds with suspected infection.
    2) VENOM DETECTION KIT
    a) An ELISA based venom detection kit has been developed for four of the common species of snakes found in Vietnam: Trimeresurus popcorum (Green pit viper), Calloselasma rhodostoma (Malayan pit viper), Naja naja (Common cobra), and Ophiophagus hannah (King cobra). Venom was detected in blister fluid (100%, wound exudate (95%), urine (67%) and blood (52%). It is not known if this detection kit is available for clinical use (Van Dong et al, 2003).

Methods

    A) BEDSIDE WHOLE BLOOD CLOTTING TEST (WBCT)
    1) A method to determine whole blood clotting can be done at the bedside with a few millimeters of venous blood placed in a new, clean, dry, glass tube (or bottle), if the patient has no history of coagulopathies. The steps are as follows and may be useful if the species is unknown or difficult to identify (Anon, 1999; Rojnuckarin et al, 2012):
    1) Place a few millimeters of venous blood in a GLASS tube
    2) Leave undisturbed for 20 minutes at room temperature
    3) Tip the vessel once:
    a) If blood is still liquid and runs out it is indicative of a venom-induced coagulopathy (VICC).
    b) Inaccurate results may occur if the vessel had been cleaned previously with detergent. Incoagulable blood is more frequently associated with viper envenomations.
    a) If there is any doubt, repeat the test and include a "control" (blood from an unexposed individual, such as a relative) (Warrell, 2010; Anon, 1999).
    b) ALTERNATIVELY, prothrombin time (PT) can be used if laboratory evaluation is available. It is also reflective of fibrinogen levels and has the advantage of being standardized (Rojnuckarin et al, 2012; Pongpit et al, 2012).
    B) DIAGNOSTIC UTILITY OF WBCT IN RUSSELL'S VIPER
    1) A prospective observational study was conducted in central western Sri Lanka to determine the diagnostic utility of the 20-minute whole blood clotting test (20WBCT) for venom induced coagulopathy (VICC) in Russell's viper envenoming. A total of 145 patients (median age 39 years, range 16 to 82 years) had Russell's viper bites that developed coagulopathy, based on detection of the venom in the serum and an INR of greater than 1.5. Of those patients, 140 had 20WBCT done at the time of admission. Testing was done by clinical staff using a protocol but no standardization of the type of tube used; this type of testing had been done for decades in this region. The results were positive in 56 of 140 patients for a sensitivity (false negative) of 40% (95% CI: 32% to 49%) and an overall specificity (false positive) of 100% (95% CI: 94% to 100%). Due to negative test results, a median delay of 1.78 hours occurred in antivenom administration compared to a positive 20WBCT test and a median delay of 0.82 hours in antivenom administration. Delays were often due to further 20WBCT testing. In addition, paired testing of 232 20WBCT and INR tests performed within the first hour of admission showed that in 221 paired tests in which the INR was greater than 1.5, 20WBCT was only positive in 91 (41%) of the tests. Of those envenomed patients with a negative 20WBCT, eventually all patients received antivenom based on clinical events (Isbister et al, 2013).
    C) UTILITY OF PROTHROMBIN TIME IN GREEN PIT VIPER
    1) In a prospective observational study of adults (n=97) bitten by a presumed green pit viper, all patients were evaluated for systemic bleeding using various blood testing methods including prothrombin time (PT) and activated partial thromboplastin time (APTT). The other methods used included: 20 minute whole blood clotting time (20WBCT), conventional venous clotting time (VCT) of greater than 30 min, and an INR of greater than 1.2. A fibrinogen level below of 1 g/L was used as the gold standard. A VCT of greater than 30 min, an INR of greater that 1.2 and a fibrinogen level of less than 1 g/L were found in 9.3%, 10,3% and 7.2%, respectively. Sensitivities (false negative) of VCT, 20WBCT (n=55), INR and APTT were 57%, 85.7%, 85.7% and 57.1%, respectively with specificities of greater than 94% for the first 3 tests and 72.4% for APTT. PT (INR greater than 1.2) was found to correlate with severe hypofibrinogenemia (fibrinogen of less than 1 g/L). 20WBCT was also found to be accurate in predicting severe hypofibrinogenemia (Pongpit et al, 2012).
    D) FALSE NEGATIVE results could occur if clot identification is read beyond 20 minutes (Stone et al, 2006).
    E) FALSE POSITIVE results could occur if polypropylene or polyethylene tubes are used instead of glass (Stone et al, 2006).
    1) ALTERNATIVE BEDSIDE METHOD
    a) BEDSIDE METHOD: A study was conducted to evaluate 2 bedside methods for measuring whole blood clotting time after a snakebite that may occur in a remote area or in areas where access to a laboratory is limited. The methods are as follows:
    1) Leave the blood drawn (approximately 5 mL) in a plastic syringe; leave it flat on a desk or taped to a wall;
    2) OR
    3) Draw blood the same as above and inject the blood into a used ceftriaxone (the interior should be dry) bottle and set on a flat surface.
    2) STUDY
    a) A blinded methodological study was conducted to determine the potential effectiveness of various plastic containers as compared to glass in performing the whole blood clotting time (WBCT) (for 20 minutes) in envenomed patients. An initial pilot study demonstrated that WBCT without venom was significantly different between glass and various plastic containers (ie, polypropylene, polyethylene and polycarbonate). Polypropylene and plain polyethylene were considered unsuitable for further testing because of their prolonged clotting times of greater than 60 minutes in the presence of venom. The findings further suggested that various venom concentrations (0 ng/mL to 100,000 ng/ml were initially tested) could significantly alter the clotting time. No clotting was observed in either the glass or polycarbonate tube for venom concentrations above 100 ng/mL. Samples of 0 ng/mL and 10 ng/mL were used in the study because they clotted in 20 minutes. Polycarbonate (mean time of 29.5 minutes in the presence of venom) was considered a suitable alternative to glass if the threshold for clot identification was increased to 35 minutes. However, the authors concluded that differentiating between various plastic materials may be difficult and polycarbonate tubes may not be readily available in all healthcare facilities; therefore, the authors recommended the continued use of glass tubes (Stone et al, 2006).
    1) LIMITATIONS: Although glass tubes have been found to be sensitive and specific indicators of severe coagulopathy, false negative results could occur if the test results are read beyond the 20 minute threshold time. Other potential limitations could include: measurement bias of clot size, container volumes were not standardized, and use of one venom type (Pseudechis australis) may influence extrapolation of findings to other venom types.
    F) ELISA
    1) Serum venom levels have been determined by ELISA (Rojnuckarin et al, 1998).
    G) EIA
    1) Pe et al (1991) described an enzyme immunoassay method using purified rabbit antivenom IgG conjugated to alkaline phosphatase type VII-L which had both specificity and sensitivity and was useful in immunodiagnosis of daboia russelii (Russell's Viper) bites. The authors also suggested that this test could be used to monitor the effectiveness of antivenom treatment and the assessment of antivenom potency (Pe et al, 1991).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.6) DISPOSITION/BITE-STING EXPOSURE
    6.3.6.1) ADMISSION CRITERIA/BITE-STING
    A) Patients with evidence of local or systemic venom effects should be admitted for further treatment and monitoring for a treatment response and possible complications.
    6.3.6.2) HOME CRITERIA/BITE-STING
    A) There is no role for home management of a suspected snake bite. The goal of prehospital care is rapid transport to a healthcare facility.
    6.3.6.3) CONSULT CRITERIA/BITE-STING
    A) Contact a medical toxicologist or local poison center for any patient with suspected viper envenomation. For patients with resulting acute renal failure and/or hyperkalemia due to rhabdomyolysis, consult a nephrologist for assistance with hemodialysis if needed.
    6.3.6.5) OBSERVATION CRITERIA/BITE-STING
    A) Any patient who has been bitten by a proven or suspected venomous viper should be observed in a hospital for 24 hours.
    B) Observe for local complications and systemic toxicity (coagulopathy and acute renal injury). Because of the potential for delayed systemic toxicity, an asymptomatic patient with normal laboratory results after 24 hours of observation should be followed as an outpatient every 12 to 24 hours for 3 days (Rojnuckarin et al, 2012).

Monitoring

    A) The following tests should be obtained upon admission and repeated to assess worsening envenomation and/or efficacy of antivenom. Obtain complete blood count with differential. Monitor clotting factors (PT or INR, PTT) and platelet count. Repeat studies every 6 hours initially at least for 24 hours, then as indicated.
    B) The 20 minute Whole Blood Clotting Test (20WBCT) or may be referred to as the Whole Blood Clotting Test 20 (WBCT20) is a simple bedside test of coagulopathy and can be used instead of clotting factors (PT or INR, PTT) if clotting factors are not available.
    C) Obtain baseline urinalysis; observe for hematuria or proteinuria. Repeat as indicated.
    D) Obtain serum electrolytes, blood urea nitrogen, and creatinine daily or as indicated.
    E) Obtain a wound culture if there is evidence of a secondary infection.

Oral Exposure

    6.5.3) TREATMENT
    A) SUPPORT
    1) See the bite/stings section for further treatment information.

Enhanced Elimination

    A) DIALYSIS
    1) Hemodialysis or peritoneal dialysis may be indicated in the presence of acute renal failure.

Summary

    A) TOXICITY: A viper bite does not always indicate that envenomation has occurred. However, "dry" bites can often result in envenomation. A single bite can result in severe envenomation or death.
    B) The family Viperidae which are represented by vipers, pit vipers and Viperinae (old world vipers) commonly produce severe localized pain and necrosis. Coagulopathies and hypotension can occur.
    C) Although NOT frequently reported, neurotoxicity can occur after envenomation by the Daboia russelii (Russell's Viper), and Chinese and Japanese Mamushis (A. b. brevicaudus and A. b. blomhoffii). The Daboia russelii can also produce acute renal failure, circulatory collapse, and rhabdomyolysis.
    D) Although these species are limited to a geographical area, bites from exotic species may occur outside their native region in reptile handlers, zoo personnel and amateur herpetologists.

Maximum Tolerated Exposure

    A) SUMMARY
    1) A viper bite does not always indicate that envenomation has occurred (Meier & White, 1995).
    2) Local tissue injury can include severe pain and moderate to severe local and regional swelling and tissue necrosis; compartment syndrome is possible following a viper envenomation (Meier & White, 1995).
    3) Coagulopathy is the primary severe systemic effect of viper envenomation (Anon, 1999). The Daboia russelii (Russell's Viper) and some other vipera are also responsible for producing hypotension and circulatory collapse, acute renal failure, mild neurotoxic symptoms and acute and chronic endocrine abnormalities (Meier & White, 1995).

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) AGKISTRODON ACUTUS-
    1) LD50- (INTRAPERITONEAL)MOUSE:
    a) 2800 mcg/kg (RTECS, 2001)
    2) LD50- (SUBCUTANEOUS)MOUSE:
    a) 9200 mcg/kg (RTECS, 2001)
    B) AGKISTRODON HALYS BLOMHOFFII-
    1) LD50- (INTRAPERITONEAL)MOUSE:
    a) 1320 mcg/kg (RTECS, 2001)
    2) LD50- (SUBCUTANEOUS)MOUSE:
    a) 13 mg/kg (RTECS, 2001)
    C) TRIMERESURUS ALBOLABRIS-
    1) LD50- (SUBCUTANEOUS)MOUSE:
    a) 12750 mcg/kg (RTECS, 2001)
    D) TRIMERESURUS ELEGANS-
    E) TRIMERESURUS FLAVOVIRIDIS-
    1) LD50- (SUBCUTANEOUS)MOUSE:
    a) 55 mg/kg (RTECS, 2001)
    F) TRIMERESURUS OKINAVENSIS-
    1) LD50- (INTRAPERITONEAL)MOUSE:
    a) 15 mg/kg (RTECS, 2001)
    G) TRIMERESURUS STEJNEGERI-
    H) TRIMERESURUS WAGLERI-
    1) LD50- (INTRAPERITONEAL)MOUSE:
    a) 3575 mcg/kg (RTECS, 2001)
    2) LD50- (SUBCUTANEOUS)MOUSE:
    a) 4625 mcg/kg (RTECS, 2001)
    I) VIPERA BERUS-
    1) LD50- (INTRAPERITONEAL)MOUSE:
    a) 860 mcg/kg (RTECS, 2001)
    2) LD50- (SUBCUTANEOUS)MOUSE:
    a) 1 mg/kg (RTECS, 2001)
    J) VIPERA RUSSELII
    1) LD50- (INTRAMUSCULAR)MOUSE:
    a) 10 mg/kg (RTECS, 2001)
    2) LD50- (INTRAPERITONEAL)MOUSE:
    a) 400 mcg/kg (RTECS, 2001)
    3) LD50- (SUBCUTANEOUS)MOUSE:
    a) 8250 mcg/kg (RTECS, 2001)
    4) LD50- (INTRAMUSCULAR)RAT:
    a) 1330 mcg/kg (RTECS, 2001)
    5) LD50- (INTRAPERITONEAL)RAT:
    a) 890 mcg/kg (RTECS, 2001)
    6) LD50- (SUBCUTANEOUS)RAT:
    a) 16250 mcg/kg (RTECS, 2001)

Toxicologic Mechanism

    A) Many species of Asian vipers which include: Russell's Viper in the Indian subcontinent and Southeast Asia, the mamushis (genus Agkistrodon Gloydius) of the Far East, the habus (genus Trimeresurus) of Japan and pit vipers (genera Calloselasma and Trimeresurus) of Southeast Asia can produce significant morbidity and mortality (Meier & White, 1995).
    B) Venoms by most vipers cause significant local injury that can develop in as little as 15 minutes or be delayed several hours. Tissue necrosis is caused by the abundant supply of proteolytic enzymes and phospholipases A(2) found in the venom (Meier & White, 1995).
    C) Hemostatic abnormalities are a distinct feature of envenomation by many vipers (Meier & White, 1995; Anon, 1999). Several specific factors are responsible for producing incoagulable blood. For instance, the Russell's viper contains several different procoagulants which activate different steps of the clotting cascade which results in the formation of fibrin in the blood. The body almost immediately begins to break down the fibrin which can result in a depletion of clotting factors in as little as 30 minutes after a bite ("consumption coagulopathy") causing the blood to no longer clot (Meier & White, 1995; Anon, 1999).
    1) Fibrinogen clotting (thrombin-like) enzymes have been isolated from the venoms of many species of Asian pit vipers (Meier & White, 1995). Factors referred to as "hemorrhagins" (zinc metalloproteinases) damage the endothelial lining of the blood vessel walls causing spontaneous systemic hemorrhage (Anon, 1999).
    2) Ancrod is a serine protease from the venom of T. flavoviridis, A. blomhoffii brevicaudus, D. acutus, O. okinavensis, T. stejnegeri, and A. ussuriensis.
    3) Factor X activity has been found in the venom of Russell's Viper (which also has Factor V), E. carinatus, and Cerastes Cerastes.
    4) Prothrombin-activating activity (Escarin) has been found in the venom of Echis carinatus.
    D) Envenomation by some vipers can result in direct myocardial toxicity as noted by cardiac dysrhythmias or abnormal ECG findings (Meier & White, 1995).
    E) The venom of Daboia russelii is responsible for producing many different clinical responses which can include: coagulopathies, anaphylaxis, acute renal failure, mild neurotoxic symptoms, acute and chronic endocrine abnormalities secondary to injury of the anterior pituitary (Meier & White, 1995).
    1) Neurotoxic effects are caused by the presence of phospholipases A(2) with presynaptic neurotoxic activity which have been found in the venoms of these species: Russell's Vipers, Chinese and Japanese Mamushis (A. b. brevicaudus and A. b. blomhoffii) and experimentally in the venom of A. intermedius (Meier & White, 1995).
    F) Phospholipases A(2) are also thought to cause generalized rhabdomyolysis that can occur after Sri Lankan Russell's Viper bites (Meier & White, 1995). They are also responsible for causing damage to cell membranes, endothelium, skeletal muscle, nerve and red blood cells (Anon, 1999).

General Bibliography

    1) American Zoo and Aquarium Association: Antivenom Index. American Zoo and Aquarium Association. Silver Spring, MD. 2007. Available from URL: http://www.aza.org/ai/index.cfm.
    2) American Zoo and Aquarium Association: Antivenom Index. American Zoo and Aquarium Association. Silver Spring, MD. 2009. Available from URL: http://www.aza.org/ai/index.cfm. As accessed 2009-04-13.
    3) Anon: WHO/SEARO guidelines for clinical management of snake bites. So Asian J Trop Med Pub Health 1999; 30 (S1):1-85.
    4) Antonypillai CN, Wass JA, Warrell DA, et al: Hypopituitarism following envenoming by Russell's vipers (Daboia siamensis and D. russelii) resembling Sheehan's syndrome: first case report from Sri Lanka, a review of the literature and recommendations for endocrine management. QJM 2011; 104(2):97-108.
    5) Aung W, Kyaw KPP, & Hla B: Renal involvement in Russell's viper bite patients without disseminated intravascular coagulation. Transact Roy Soc Trop Med Hyg 1998; 92:322-324.
    6) Brown CV, Rhee P, Chan L, et al: Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?. J Trauma 2004; 56(6):1191-1196.
    7) Buranasin P: Snakebites at Maharat Nakhon Ratchasima Regional hospital. Southeast Asian J Trop Med Pub Health 1993; 24:186-192.
    8) Camp NE: Drug- and toxin-induced Rhabdomyolysis. J Emerg Nurs 2009; 35(5):481-482.
    9) Chan TYK, Chan JCN, & Tomlinson B: Clinical features and hospital management of bites by the white-lipped green pit viper (Trimeresurus albolabris). SE Asian J Trop Med Pub Health 1993; 24:772-775.
    10) Chan TYK, Kwok MMY, & Cockram CS: Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong. Singapore Med J 1993a; 34:145-147.
    11) Chang KP, Lai CS, & Lin SD: Management of poisonous snake bites in southern Taiwan. Kaohsiung J Med Sci 2007; 23(10):511-518.
    12) Chen CC, Yang CM, Hu FR, et al: Penetrating ocular injury caused by venomous snakebite. Am J Opthal 2005; 140(3):544-546.
    13) Chen YC, Chen MH, Yang CC, et al: Trimeresurus stejnegeri envenoming during pregnancy. Am J Trop Med Hyg 2007; 77(5):847-849.
    14) Clark RF & Davidson TM: Intraarticular envenomation by Trimeresurus flavomaculatus mcgregori resulting in joint destruction. Toxicon 1997; 6:837-842.
    15) Cockram CS, Chan JCN, & Chow KY: Bites by the white-lipped pit viper (Trimeresurus albolabris) and other species in Hong Kong. A survey of 4 years' experience at the Prince of Wales hospital. J Trop Med Hyg 1990; 93:79-86.
    16) Criddle LM: Rhabdomyolysis. Pathophysiology, recognition, and management. Crit Care Nurse 2003; 23(6):14-22, 24-26, 28.
    17) Erdman AR & Dart RC: Rhabdomyolysis. In: Dart RC, Caravati EM, McGuigan MA, et al, eds. Medical Toxicology, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2004, pp 123-127.
    18) Homsi E, Barreiro MF, Orlando JM, et al: Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail 1997; 19(2):283-288.
    19) Huerta-Alardin AL, Varon J, & Marik PE: Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care 2005; 9(2):158-169.
    20) Hung D, Yu y, Hsu C, et al: Antivenom treatment and renal dysfunction in Russell's viper snakebite in Taiwan: a case series. Trans R Soc Trop Med Hyg 2006; 100(5):489-494.
    21) Hutton RA, Looareesuwan S, & Ho M: Aboreal green pit vipers (genus Trimeresurus) of south east Asia: bites by T. albolabris and T. macrops in Thailand and a review of the literature. Transact Roy Soc Trop Med Hyg 1990; 84:866-874.
    22) Isbister GK, Maduwage K, & Page CB: Antivenom cross neutralisation in a suspected Asian pit viper envenoming causing severe coagulopathy. Toxicon 2014; 90:286-290.
    23) Isbister GK, Maduwage K, Shahmy S, et al: Diagnostic 20-min whole blood clotting test in Russell's viper envenoming delays antivenom administration. QJM 2013; 106(10):925-932.
    24) Isbister GK, Shahmy S, Mohamed F, et al: A randomised controlled trial of two infusion rates to decrease reactions to antivenom. PLoS One 2012; 7(6):e38739.
    25) Ittyachen AM & Jose MB: Thalamic infarction following a Russell's viper bite. Southeast Asian J Trop Med Public Health 2012; 43(5):1201-1204.
    26) Iwakiri R, Fujimoto K, & Hirano M: Snake-strike-induced ischemic colitis with colonic stricture complicated by disseminated intravascular coagulation. Southern Med J 1995; 88:1084-1085.
    27) Jacob J: Viper bite with continuous defibrination despite adequate treatment with antivenom. J Assoc Physicians India 2006; 54:733-734.
    28) Joseph JK, Simpson ID, Menon NC, et al: First authenticated cases of life-threatening envenoming by the hump-nosed pit viper (Hypnale hypnale) in India. Trans R Soc Trop Med Hyg 2007; 101(1):85-90.
    29) Kleinman ME, Chameides L, Schexnayder SM, et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 14: pediatric advanced life support. Circulation 2010; 122(18 Suppl.3):S876-S908.
    30) Kochar DK, Tanwar PD, Norris RL, et al: Rediscovery of severe saw-scaled viper (Echis sochureki) envenoming in the Thar desert region of Rajasthan, India. Wilderness Environ Med 2007; 18(2):75-85.
    31) Kuo TP & Wu CS: Clinico-pathological studies on snakebites in Taiwan. JFMA 1972; 71:447-466.
    32) Li QB, Yu QS, & Huang GW: Hemostatic disturbances observed in patients with snakebite in south China. Toxicon 2000; 38:1355-1366.
    33) Lieberman P, Nicklas R, Randolph C, et al: Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol 2015; 115(5):341-384.
    34) Lieberman P, Nicklas RA, Oppenheimer J, et al: The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126(3):477-480.
    35) Meier J & White J: ., Handbook of Clinical Toxicology and Animal Venoms and Poisons, CRC Press, Boca Raton, FL, 1995a.
    36) Meier J & White J: Handbook of Clinical Toxicology and Animal Venoms and Poisons, CRC Press, Boca Raton, FL, 1995.
    37) Mohapatra BN & Mohanty CBK: Guidelines for anti snake venom therapy. Med Update 2010; 20:426-430.
    38) Moore TC: Snakebite from the Korean pit viper. Military Med 1977; 142:546-549.
    39) Murase K & Takagi K: Takotsubo cardiomyopathy in a snake bite victim: a case report. Pan Afr Med J 2012; 13:51.
    40) Nasu K, Ueda T, & Miyakawa I: Intrauterine fetal death caused by pit viper venom poisoning in early pregnancy. Gynecol Obstet Invest 2004; 57:114-116.
    41) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    42) Nowak RM & Macias CG : Anaphylaxis on the other front line: perspectives from the emergency department. Am J Med 2014; 127(1 Suppl):S34-S44.
    43) Pe T, Aye B, & Myint AA: Bites by Russell's vipers (Daboia russelii siamensis) in Mynamar: effect of the snake's length and recent feeding on venom antigenaemia and severity of envenoming. Transact Roy Soc Trop Med Hyg 1991; 85:804-808.
    44) Pe T, Myint AA, & Han KE: Local compression pads as a first-aid measure for victims of bites by Russell's viper (Daboia russelii siamensis) in Myanmar. Transact Roy Soc Trop Med Hyg 1995; 89:293-295.
    45) Peberdy MA , Callaway CW , Neumar RW , et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care science. Part 9: post–cardiac arrest care. Circulation 2010; 122(18 Suppl 3):S768-S786.
    46) Polderman KH: Acute renal failure and rhabdomyolysis. Int J Artif Organs 2004; 27(12):1030-1033.
    47) Pongpit J, Limpawittayakul P, Juntiang J, et al: The role of prothrombin time (PT) in evaluating green pit viper (Cryptelytrops sp) bitten patients. Trans R Soc Trop Med Hyg 2012; 106(7):415-418.
    48) Product Information: diphenhydramine HCl intravenous injection solution, intramuscular injection solution, diphenhydramine HCl intravenous injection solution, intramuscular injection solution. Hospira, Inc. (per DailyMed), Lake Forest, IL, 2013.
    49) Product Information: dopamine hcl, 5% dextrose IV injection, dopamine hcl, 5% dextrose IV injection. Hospira,Inc, Lake Forest, IL, 2004.
    50) Product Information: norepinephrine bitartrate injection, norepinephrine bitartrate injection. Sicor Pharmaceuticals,Inc, Irvine, CA, 2005.
    51) Punguyire D, Iserson KV, Stolz U, et al: Bedside whole-blood clotting times: validity after snakebites. J Emerg Med 2013; 44(3):663-667.
    52) Rojnuckarin P, Chanthawibun W, Noiphrom J, et al: A randomized, double-blind, placebo-controlled trial of antivenom for local effects of green pit viper bites. Trans R Soc Trop Med Hyg 2006; 100(9):879-884.
    53) Rojnuckarin P, Mahasandana S, & Intragumthornchai T: Prognostic factors of green pit viper bites. Am J Trop Med Hyg 1998; 58:22-25.
    54) Rojnuckarin P, Suteparak S, & Sibunruang S: Diagnosis and management of venomous snakebites in Southeast Asia. Asian Biomed 2012; 6(6):795-805.
    55) Sharma N, Chauhan S, Faruqi S, et al: Snake envenomation in a north Indian hospital. Emerg Med 2005; 22:118-120.
    56) Soogarun S, Wiwanitkit V, & Suwansaksri J: A trend of platelet indices in patients with green pit viper toxin. Clin Appl Thrombosis/Hemostasis 2003; 9(4):337-339.
    57) Stone R, Seymour J, & Marshall O: Plastic containers and the whole-blood clotting test: glass remains the best option. Trans R Soc Trop Med Hyg 2006; 100(12):1168-1172.
    58) Swe TN, Khin M, & Thwin MM: Acute changes in serum cortisol levels following Russell's viper bites in Myanamar. SE Asian J Trop Med Pub Health 1997; 28:399-403.
    59) Than T, Tun T, & Pe H: Development of renal function abnormalities following bites by Russell's vipers (Daboia russelii siamensis) in Myanmar. Transact Roy Soc Trop Med Hyg 1991; 85:404-409.
    60) USDN: Poisonous Snakes of the World, U.S. Department of the Navy, Bureau of Medicine and Surgery, Dover Publications, Inc, New York, NY, 1991.
    61) Van Dong L, Quyen LK, Eng KH, et al: Immunogenicity of venoms from four common snakes in the south of Vietnam and development of ELISA kit for venom detection. J Immunological Methods 2003; 282:13-31.
    62) Vanden Hoek,TL; Morrison LJ; Shuster M; et al: Part 12: Cardiac Arrest in Special Situations 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. American Heart Association. Dallas, TX. 2010. Available from URL: http://circ.ahajournals.org/cgi/reprint/122/18_suppl_3/S829. As accessed 2010-10-21.
    63) Vanholder R, Sever MS, Erek E, et al: Rhabdomyolysis. J Am Soc Nephrol 2000; 11(8):1553-1561.
    64) Vest DK & Kardong KV: Envenomation by a juvenile Malayan pit viper (Agkistrodon rhodostoma). Clin Toxicol 1980; 16:299-303.
    65) Viravan C, Looareesuwan S, & Kosakarn W: A national hospital-based survey of snakes responsible for bites in Thailand. Transact Roy Soc Trop Med Hyg 1992; 86:100-106.
    66) Walter LA & Catenacci MH: Rhabdomyolysis. Hosp Physician 2008; 44(1):25-31.
    67) Warrell DA: Guidelines for the management of snake bites. World Health Organization Regional Office for South-East Asia. New Delhi, India. 2010. Available from URL: http://www.toxinology.org/resources/protocols/WHO-SEARO%20Snakebite%20Guidelines%202010%20copy.pdf. As accessed 2014-03-10.
    68) Yang JY, Hui H, & Lee AC: Severe coagulopathy associated with white-lipped green pit viper bite. Hong Kong Med J 2007; 13(5):392-395.
    69) denEndenErwin V & Emmanuel B: Envenoming by the viperid snake Eristicophis macmahonii. Toxicon 2005; 46(8):918-920.